{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,23]],"date-time":"2023-12-23T05:30:24Z","timestamp":1703309424088},"reference-count":68,"publisher":"Japanese Association of Virology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Uirusu"],"published-print":{"date-parts":[[2014]]},"DOI":"10.2222\/jsv.64.67","type":"journal-article","created":{"date-parts":[[2015,3,9]],"date-time":"2015-03-09T22:08:24Z","timestamp":1425938904000},"page":"67-74","source":"Crossref","is-referenced-by-count":1,"title":["History of resaerch on Epstein-Barr virus"],"prefix":"10.2222","volume":"64","author":[{"given":"Shouichi","family":"OHGA","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Yamaguchi University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1062","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1)Epstein MA, Achong BG, Barr YM. Virus particles in cultures lymphoblasts from Burkitt's lymphoma. Lancet. 1964;1(7335):702-3.","DOI":"10.1016\/S0140-6736(64)91524-7"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2)Thorley-Lawson DA, Hawkins JB, Tracy SI, Shapiro M. The pathogenesis of Epstein-Barr virus persistent infection. Curr Opin Virol. 2013;3(3):227-32.","DOI":"10.1016\/j.coviro.2013.04.005"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3)Rickinson AB. Co-infections, inflammation and oncogenesis: Future directions for EBV research. Semin Cancer Biol. 2014 (in press)","DOI":"10.1016\/j.semcancer.2014.04.004"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4)Nemerow GR, Wolfert R, McNaughton ME, Cooper NR. Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2). J Virol. 1985;55(2):347-51.","DOI":"10.1128\/JVI.55.2.347-351.1985"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5)Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer. 2004 ;4(10):757-68.","DOI":"10.1038\/nrc1452"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6)Ohga S, Nomura A, Takada H, Hara T: Epstein-Barr virus associated diseases in childhood.-Immunological aspects of Epstein-Barr virus infection. Crit Rev Oncol Hematol. 2002; 44:203-15.","DOI":"10.1016\/S1040-8428(02)00112-9"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7)Faulkner GC, Burrows SR, Khanna R, Moss DJ, Bird AG, Crawford DH. X-Linked agammaglobulinemia patients are not infected with Epstein-Barr virus: implications for the biology of the virus. J Virol. 1999 ;73(2):1555-64.","DOI":"10.1128\/JVI.73.2.1555-1564.1999"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8)Anagnostopoulos I, Hummel M, Kreschel C, Stein H. Morphology, immunophenotype, and distribution of latently and\/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: implications for the interindividual infection route of Epstein-Barr virus. Blood. 1995;85(3):744-50.","DOI":"10.1182\/blood.V85.3.744.bloodjournal853744"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9)Imai S, Sugiura M, Oikawa O, Koizumi S, Hirao M, Kimura H, Hayashibara H, Terai N, Tsutsumi H, Oda T, Chiba S, Osato T. Epstein-Barr virus (EBV)-carrying and -expressing T-cell lines established from severe chronic active EBV infection. Blood. 1996 ;87(4):1446-57.","DOI":"10.1182\/blood.V87.4.1446.bloodjournal8741446"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10)Oyoshi MK1, Nagata H, Kimura N, Zhang Y, Demachi A, Hara T, Kanegane H, Matsuo Y, Yamaguchi T, Morio T, Hirano A, Shimizu N, Yamamoto K. Preferential expansion of Vgamma9-JgammaP\/Vdelta2-Jdelta3 gammadelta T cells in nasal T-cell lymphoma and chronic active Epstein-Barr virus infection. Am J Pathol. 2003 ;162(5):1629-38.","DOI":"10.1016\/S0002-9440(10)64297-6"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11)Thiel J, Kimmig L, Salzer U, Grudzien M, Lebrecht D, Hagena T, Draeger R, Voelxen N, Bergbreiter A, Jennings S, Gutenberger S, Aichem A, Illges H, Hannan JP, Kienzler AK, Rizzi M, Eibel H, Peter HH, Warnatz K, Grimbacher B, Rump JA, Schlesier M. Genetic CD21 deficiency is associated with hypogammaglobulinemia. J Allergy Clin Immunol. 2012 ;129(3):801-10.","DOI":"10.1016\/j.jaci.2011.09.027"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12)Ogembo JG, Kannan L, Ghiran I, Nicholson-Weller A, Finberg RW, Tsokos GC, Fingeroth JD. Human complement receptor type 1\/CD35 is an Epstein-Barr Virus receptor. Cell Rep. 2013 ;3(2):371-85.","DOI":"10.1016\/j.celrep.2013.01.023"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13)Tempera I, Lieberman PM. Epigenetic regulation of EBV persistence and oncogenesis. Semin Cancer Biol. 2014 (in press)","DOI":"10.1016\/j.semcancer.2014.01.003"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14)Klinke O, Feederle R, Delecluse HJ. Genetics of Epstein-Barr virus microRNAs. Semin Cancer Biol. 2014 (in press)","DOI":"10.1016\/j.semcancer.2014.02.002"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15)Oh JH, Kim YJ, Moon S, Nam HY, Jeon JP, Lee JH, Lee JY, Cho YS. Genotype instability during long-term subculture of lymphoblastoid cell lines. J Hum Genet. 2013 ;58(1):16-20.","DOI":"10.1038\/jhg.2012.123"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16)Arvey A, Tempera I, Tsai K, Chen HS, Tikhmyanova N, Klichinsky M, Leslie C, Lieberman PM. An atlas of the Epstein-Barr virus transcriptome and epigenome reveals host-virus regulatory interactions. Cell Host Microbe. 2012 ;12(2):233-45.","DOI":"10.1016\/j.chom.2012.06.008"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17)Dunmire SK, Odumade OA, Porter JL, Reyes-Genere J, Schmeling DO, Bilgic H, Fan D, Baechler EC, Balfour HH Jr, Hogquist KA. Primary EBV infection induces an expression profile distinct from other viruses but similar to hemophagocytic syndromes. PLoS One. 2014;9(1):e85422.","DOI":"10.1371\/journal.pone.0085422"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18)Ohga S, Nomura A, Takada H, Tanaka T, Furuno K, Takahata Y, Kinukawa N, Fukushima N, Imai S, Hara T. Dominant expression of interleukin-10 and transforming growth factor-beta genes in activated T-cells of chronic active Epstein-Barr virus infection. J Med Virol. 2004 ;74(3):449-58.","DOI":"10.1002\/jmv.20197"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19)Zauner L, Nadal D. Understanding TLR9 action in Epstein-Barr virus infection. Front Biosci (Landmark Ed). 2012 ;17:1219-31.","DOI":"10.2741\/3982"},{"key":"20","doi-asserted-by":"crossref","unstructured":"21)Moumad K, Lascorz J, Bevier M, Khyatti M, Ennaji MM, Benider A, Huhn S, Lu S, Chouchane L, Corbex M, Hemminki K, Frsti A. Genetic polymorphisms in host innate immune sensor genes and the risk of nasopharyngeal carcinoma in North Africa. G3 (Bethesda). 2013 ;3(6):971-7.","DOI":"10.1534\/g3.112.005371"},{"key":"21","doi-asserted-by":"crossref","unstructured":"22)Valente RM, Ehlers E, Xu D, Ahmad H, Steadman A, Blasnitz L, Zhou Y, Kastanek L, Meng B, Zhang L. Toll-like receptor 7 stimulates the expression of Epstein-Barr virus latent membrane protein 1. PLoS One. 2012;7(8):e43317.","DOI":"10.1371\/journal.pone.0043317"},{"key":"22","doi-asserted-by":"crossref","unstructured":"23)Morissette G, Flamand L. Herpesviruses and chromosomal integration. J Virol. 2010 ;84(23):12100-9.","DOI":"10.1128\/JVI.01169-10"},{"key":"23","doi-asserted-by":"crossref","unstructured":"24)Khoury JD, Tannir NM, Williams MD, Chen Y, Yao H, Zhang J, Thompson EJ; TCGA Network, Meric-Bernstam F, Medeiros LJ, Weinstein JN, Su X. Landscape of DNA virus associations across human malignant cancers: analysis of 3,775 cases using RNA-Seq. J Virol. 2013 ;87(16):8916-26.","DOI":"10.1128\/JVI.00340-13"},{"key":"24","doi-asserted-by":"crossref","unstructured":"25)Tran H, Nourse J, Hall S, Green M, Griffiths L, Gandhi MK. Immunodeficiency-associated lymphomas. Blood Rev. 2008 ;22(5):261-81.","DOI":"10.1016\/j.blre.2008.03.009"},{"key":"25","doi-asserted-by":"crossref","unstructured":"26)Bax HI, Freeman AF, Anderson VL, Vesterhus P, Laerum D, Pittaluga S, Wilson WH, Holland SM. B-cell lymphoma in a patient with complete interferon gamma receptor 1 deficiency. J Clin Immunol. 2013 ;33(6):1062-6.","DOI":"10.1007\/s10875-013-9907-0"},{"key":"26","doi-asserted-by":"crossref","unstructured":"27)Draborg AH, Duus K, Houen G. Epstein-Barr virus in systemic autoimmune diseases. Clin Dev Immunol. 2013 ;2013:535738","DOI":"10.1155\/2013\/535738"},{"key":"27","doi-asserted-by":"crossref","unstructured":"28)Kivity S, Arango MT, Ehrenfeld M, Tehori O, Shoenfeld Y, Anaya JM, Agmon-Levin N. Infection and autoimmunity in Sjogren's syndrome: A clinical study and comprehensive review. J Autoimmun. 2014 (in press)","DOI":"10.1016\/j.jaut.2014.02.008"},{"key":"28","doi-asserted-by":"crossref","unstructured":"29)Takeuchi M, Sato Y, Yasui H, Ozawa H, Ohno K, Takata K, Gion Y, Orita Y, Tachibana T, Itoh T, Asano N, Nakamura S, Swerdlow SH, Yoshino T. Epstein-Barr Virus-infected Cells in IgG4-related Lymphadenopathy With Comparison With Extranodal IgG4-related Disease. Am J Surg Pathol. 2014 (in press)","DOI":"10.1097\/PAS.0000000000000206"},{"key":"29","doi-asserted-by":"crossref","unstructured":"30)Ruprecht K, Wunderlich B, Gie R, Meyer P, Loebel M, Lenz K, Hofmann J, Rosche B, Wengert O, Paul F, Reimer U, Scheibenbogen C. Multiple sclerosis: The elevated antibody response to Epstein-Barr virus primarily targets, but is not confined to, the glycine-alanine repeat of Epstein-Barr nuclear antigen-1. J Neuroimmunol. 2014 (in press)","DOI":"10.1016\/j.jneuroim.2014.04.005"},{"key":"30","doi-asserted-by":"crossref","unstructured":"31)Ozcan D, Sekin D, Bileziki B, Arslan H. The role of human herpesvirus-6, EpsteinBarr virus and cytomegalovirus infections in the etiopathogenesis of different types of cutaneous drug reactions. Int J Dermatol. 2010 ;49(11):1250-4.","DOI":"10.1111\/j.1365-4632.2010.04531.x"},{"key":"31","doi-asserted-by":"crossref","unstructured":"32)Okano M, Gross TG. Acute or chronic life-threatening diseases associated with Epstein-Barr virus infection. Am J Med Sci. 2012 ;343(6):483-9.","DOI":"10.1097\/MAJ.0b013e318236e02d"},{"key":"32","doi-asserted-by":"crossref","unstructured":"33)Yachie A, Kanegane H, Kasahara Y. Epstein-Barr virus-associated T-\/natural killer cell lymphoproliferative diseases. Semin Hematol. 2003 ;40(2):124-32.","DOI":"10.1016\/S0037-1963(03)70004-3"},{"key":"33","doi-asserted-by":"crossref","unstructured":"34)Kasahara Y, Yachie A, Takei K, Kanegane C, Okada K, Ohta K, Seki H, Igarashi N, Maruhashi K, Katayama K, Katoh E, Terao G, Sakiyama Y, Koizumi S. Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Blood. 2001 ;98(6):1882-8.","DOI":"10.1182\/blood.V98.6.1882"},{"key":"34","doi-asserted-by":"crossref","unstructured":"35)Okano M, Kawa K, Kimura H, Yachie A, Wakiguchi H, Maeda A, Imai S, Ohga S, Kanegane H, Tsuchiya S, Morio T, Mori M, Yokota S, Imashuku S. Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection. Am J Hematol. 2005 ;80(1):64-9.","DOI":"10.1002\/ajh.20398"},{"key":"35","doi-asserted-by":"crossref","unstructured":"36)Kimura H, Morishima T, Kanegane H, Ohga S, Hoshino Y, Maeda A, Imai S, Okano M, Morio T, Yokota S, Tsuchiya S, Yachie A, Imashuku S, Kawa K, Wakiguchi H; Japanese Association for Research on Epstein-Barr Virus and Related Diseases. Prognostic factors for chronic active Epstein-Barr virus infection. J Infect Dis. 2003 ;187(4):527-33.","DOI":"10.1086\/367988"},{"key":"36","doi-asserted-by":"crossref","unstructured":"37)Kelesidis T, Humphries R, Terashita D, Eshaghian S, Territo MC, Said J, Lewinski M, Currier JS, Pegues D. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Los Angeles County. J Med Virol. 2012 ;84(5):777-85.","DOI":"10.1002\/jmv.23267"},{"key":"37","doi-asserted-by":"crossref","unstructured":"38)Risma K, Jordan MB. Hemophagocytic lymphohistiocytosis: updates and evolving concepts. Curr Opin Pediatr. 2012 ;24(1):9-15.","DOI":"10.1097\/MOP.0b013e32834ec9c1"},{"key":"38","doi-asserted-by":"crossref","unstructured":"39)Parvaneh N, Filipovich AH, Borkhardt A. Primary immunodeficiencies predisposed to Epstein-Barr virus-driven haematological diseases. Br J Haematol. 2013 ;162(5):573-86.","DOI":"10.1111\/bjh.12422"},{"key":"39","doi-asserted-by":"crossref","unstructured":"40)Koganti S, de la Paz A, Freeman AF, Bhaduri-McIntosh S. B lymphocytes from patients with a hypomorphic mutation in STAT3 resist Epstein-Barr virus-driven cell proliferation. J Virol. 2014 ;88(1):516-24.","DOI":"10.1128\/JVI.02601-13"},{"key":"40","doi-asserted-by":"crossref","unstructured":"41)Yang X, Kanegane H, Nishida N, Imamura T, Hamamoto K, Miyashita R, Imai K, Nonoyama S, Sanayama K, Yamaide A, Kato F, Nagai K, Ishii E, van Zelm MC, Latour S, Zhao XD, Miyawaki T. Clinical and genetic characteristics of XIAP deficiency in Japan. J Clin Immunol. 2012 ;32(3):411-20.","DOI":"10.1007\/s10875-011-9638-z"},{"key":"41","doi-asserted-by":"crossref","unstructured":"42)Huck K, Feyen O, Niehues T, Rschendorf F, Hbner N, Laws HJ, Telieps T, Knapp S, Wacker HH, Meindl A, Jumaa H, Borkhardt A. Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation. J Clin Invest. 2009 ;119(5):1350-8.","DOI":"10.1172\/JCI37901"},{"key":"42","doi-asserted-by":"crossref","unstructured":"43)Veillette A, Prez-Quintero LA, Latour S. X-linked lymphoproliferative syndromes and related autosomal recessive disorders. Curr Opin Allergy Clin Immunol. 2013 ;13(6):614-22.","DOI":"10.1097\/ACI.0000000000000008"},{"key":"43","doi-asserted-by":"crossref","unstructured":"44)Nagai K, Ochi F, Terui K, Maeda M, Ohga S, Kanegane H, Kitoh T, Kogawa K, Suzuki N, Ohta S, Ishida Y, Okamura T, Wakiguchi H, Yasukawa M, Ishii E. Clinical characteristics and outcomes of chdiak-Higashi syndrome: a nationwide survey of Japan. Pediatr Blood Cancer. 2013 ;60(10):1582-6.","DOI":"10.1002\/pbc.24637"},{"key":"44","doi-asserted-by":"crossref","unstructured":"45)Li FY1, Chaigne-Delalande B, Su H, Uzel G, Matthews H, Lenardo MJ. XMEN disease: a new primary immunodeficiency affecting Mg2+ regulation of immunity against Epstein-Barr virus. Blood. 2014 ;123(14):2148-52.","DOI":"10.1182\/blood-2013-11-538686"},{"key":"45","doi-asserted-by":"crossref","unstructured":"46)Yang X, Wada T, Imadome K, Nishida N, Mukai T, Fujiwara M, Kawashima H, Kato F, Fujiwara S, Yachie A, Zhao X, Miyawaki T, Kanegane H. Characterization of Epstein-Barr virus (EBV)-infected cells in EBV-associated hemophagocytic lymphohistiocytosis in two patients with X-linked lymphoproliferative syndrome type 1 and type 2. Herpesviridae. 2012 ;3(1):1.","DOI":"10.1186\/2042-4280-3-1"},{"key":"46","doi-asserted-by":"crossref","unstructured":"47)Shiraishi A, Ohga S, Doi T, Ishimura M, Takimoto T, Takada H, Miyamoto T, Abe Y, Hara T. Treatment choice of immunotherapy or further chemotherapy for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2012 ;59(2):265-70.","DOI":"10.1002\/pbc.24039"},{"key":"47","doi-asserted-by":"crossref","unstructured":"48)Kogawa K, Sato H, Asano T, Ohga S, Kudo K, Morimoto A, Ohta S, Wakiguchi H, Kanegane H, Oda M, Ishii E. Prognostic factors of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children: Report of the Japan Histiocytosis Study Group. Pediatr Blood Cancer. 2014 ;61(7):1257-62.","DOI":"10.1002\/pbc.24980"},{"key":"48","doi-asserted-by":"crossref","unstructured":"49)Cohen JI, Jaffe ES, Dale JK, Pittaluga S, Heslop HE, Rooney CM, Gottschalk S, Bollard CM, Rao VK, Marques A, Burbelo PD, Turk SP, Fulton R, Wayne AS, Little RF, Cairo MS, El-Mallawany NK, Fowler D, Sportes C, Bishop MR, Wilson W, Straus SE. Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. Blood. 2011 ;117(22):5835-49.","DOI":"10.1182\/blood-2010-11-316745"},{"key":"49","doi-asserted-by":"crossref","unstructured":"50)Kimura H, Ito Y, Kawabe S, Gotoh K, Takahashi Y, Kojima S, Naoe T, Esaki S, Kikuta A, Sawada A, Kawa K, Ohshima K, Nakamura S. EBV-associated T\/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. Blood. 2012 ;119(3):673-86.","DOI":"10.1182\/blood-2011-10-381921"},{"key":"50","doi-asserted-by":"crossref","unstructured":"51)Cohen JI, Kimura H, Nakamura S, Ko YH and Jaffe ES: Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008. Ann Oncol. 2009; 20:1472-82.","DOI":"10.1093\/annonc\/mdp064"},{"key":"51","doi-asserted-by":"crossref","unstructured":"52)Kawa K, Sawada A, Sato M, Okamura T, Sakata N, Kondo O, Kimoto T, Yamada K, Tokimasa S, Yasui M and Inoue M: Excellent outcome of allogeneic hematopoietic SCT with reduced-intensity conditioning for the treatment of chronic active EBV infection. Bone Marrow Transplant. 2011; 46:77-83.","DOI":"10.1038\/bmt.2010.122"},{"key":"52","doi-asserted-by":"crossref","unstructured":"53)Sonke GS, Ludwig I, van Oosten H, Baars JW, Meijer E, Kater AP and de Jong D: Poor outcomes of chronic active Epstein-Barr virus infection and hemophagocytic lymphohistiocytosis in non-Japanese adult patients. Clin Infect Dis. 2008; 47:105-8.","DOI":"10.1086\/588790"},{"key":"53","doi-asserted-by":"crossref","unstructured":"54)Beutel K, Gross-Wieltsch U, Wiesel T, Stadt UZ, Janka G and Wagner HJ: Infection of T lymphocytes in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children of non-Asian origin. Pediatr Blood Cancer 2009; 53:184-90.","DOI":"10.1002\/pbc.22037"},{"key":"54","doi-asserted-by":"crossref","unstructured":"55)Fox CP, Shannon-Lowe C, Gothard P, Kishore B, Neilson J, O'Connor N and Rowe M: Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults characterized by high viral genome load within circulating natural killer cells. Clin Infect Dis. 2010; 51:66-9.","DOI":"10.1086\/653424"},{"key":"55","doi-asserted-by":"crossref","unstructured":"56)Klion AD, Mejia R, Cowen EW, Dowdell KC, Dunleavy K, Fahle GA, Holland-Thomas N, Maric I, Pittaluga S, Raffeld M, Santos C, Stetler-Stevenson M, Krogmann T, Shatzer AN, Turk SP, Yin Y, Xi L, Prussin C, Cohen JI. Chronic active Epstein-Barr virus infection: a novel cause of lymphocytic variant hypereosinophilic syndrome. Blood. 2013; 121(12):2364-6.","DOI":"10.1182\/blood-2012-12-472720"},{"key":"56","doi-asserted-by":"crossref","unstructured":"57)Elazary AS, Wolf DG, Amir G, Avni B, Rund D, Yehuda DB and Sviri S: Severe Epstein-Barr virus-associated hemophagocytic syndrome in six adult patients. J Clin Virol. 2007; 40:156-9.","DOI":"10.1016\/j.jcv.2007.06.014"},{"key":"57","doi-asserted-by":"crossref","unstructured":"59)Chellapandian D, Das R, Zelley K, Wiener SJ, Zhao H, Teachey DT, Nichols KE; EBV-HLH Rituximab Study Group. Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens. Br J Haematol. 2013;162(3):376-82.","DOI":"10.1111\/bjh.12386"},{"key":"58","doi-asserted-by":"crossref","unstructured":"60)Nasimuzzaman M1, Kuroda M, Dohno S, Yamamoto T, Iwatsuki K, Matsuzaki S, Mohammad R, Kumita W, Mizuguchi H, Hayakawa T, Nakamura H, Taguchi T, Wakiguchi H, Imai S. Eradication of Epstein-Barr virus episome and associated inhibition of infected tumor cell growth by adenovirus vector-mediated transduction of dominant-negative EBNA1. Mol Ther. 2005 ;11(4):578-90.","DOI":"10.1016\/j.ymthe.2004.12.017"},{"key":"59","doi-asserted-by":"crossref","unstructured":"61)Chatterjee B, Leung CS, Mnz C. Animal models of Epstein Barr virus infection. J Immunol Methods. 2014 (in press).","DOI":"10.1016\/j.jim.2014.04.009"},{"key":"60","doi-asserted-by":"crossref","unstructured":"62)Yajima M1, Imadome K, Nakagawa A, Watanabe S, Terashima K, Nakamura H, Ito M, Shimizu N, Yamamoto N, Fujiwara S. T cell-mediated control of Epstein-Barr virus infection in humanized mice. J Infect Dis. 2009 ;200(10):1611-5.","DOI":"10.1086\/644644"},{"key":"61","doi-asserted-by":"crossref","unstructured":"63)Sato K, Misawa N, Nie C, Satou Y, Iwakiri D, Matsuoka M, Takahashi R, Kuzushima K, Ito M, Takada K, Koyanagi Y. A novel animal model of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in humanized mice. Blood. 2011 ;117(21):5663-73.","DOI":"10.1182\/blood-2010-09-305979"},{"key":"62","doi-asserted-by":"crossref","unstructured":"64)Imadome K, Yajima M, Arai A, Nakazawa A, Kawano F, Ichikawa S, Shimizu N, Yamamoto N, Morio T, Ohga S, Nakamura H, Ito M, Miura O, Komano J, Fujiwara S. Novel mouse xenograft models reveal a critical role of CD4+ T cells in the proliferation of EBV-infected T and NK cells. PLoS Pathog. 2011;7(10):e 1002326.","DOI":"10.1371\/journal.ppat.1002326"},{"key":"63","doi-asserted-by":"crossref","unstructured":"65)Toyabe S, Harada W and Uchiyama M: Biclonal expansion of T cells infected with monoclonal Epstein-Barr virus (EBV) in a patient with chronic, active EBV infection. Clin Exp Immunol. 2003; 134:92-7.","DOI":"10.1046\/j.1365-2249.2003.02270.x"},{"key":"64","doi-asserted-by":"crossref","unstructured":"66)Endo R, Yoshioka M, Ebihara T, Ishiguro N, Kikuta H and Kobayashi K: Clonal expansion of multiphenotypic Epstein-Barr virus-infected lymphocytes in chronic active Epstein-Barr virus infection. Med Hypotheses. 2004; 63:582-7.","DOI":"10.1016\/j.mehy.2004.03.012"},{"key":"65","doi-asserted-by":"crossref","unstructured":"67)Paterson RL, Kelleher C, Amankonah TD, Streib JE, Xu JW, Jones JF, Gelfand EW. Model of Epstein-Barr virus infection of human thymocytes: expression of viral genome and impact on cellular receptor expression in the T-lymphoblastic cell line, HPB-ALL. Blood. 1995 ;85(2):456-64.","DOI":"10.1182\/blood.V85.2.456.456"},{"key":"66","doi-asserted-by":"crossref","unstructured":"68)Ohga S, Ishimura M, Yoshimoto G, Miyamoto T, Takada H, Tanaka T, Ohshima K, Ogawa Y, Imadome K, Abe Y, Akashi K, Hara T. Clonal origin of Epstein-Barr virus (EBV)-infected T\/NK-cell subpopulations in EBV-positive T\/NK-cell lymphoproliferative disorders of childhood. J Clin Virol. 2011 ;51(1):31-7.","DOI":"10.1016\/j.jcv.2011.01.014"},{"key":"67","doi-asserted-by":"crossref","unstructured":"69)Balfour HH Jr. Progress, prospects, and problems in Epstein-Barr virus vaccine development. Curr Opin Virol. 2014 (in press)","DOI":"10.1016\/j.coviro.2014.02.005"},{"key":"68","doi-asserted-by":"crossref","unstructured":"70)Villarreal L. Viruses and host evolution: virus-mediated self identity. Adv Exp Med Biol. 2012;738:185-217.","DOI":"10.1007\/978-1-4614-1680-7_12"}],"container-title":["Uirusu"],"original-title":["EB\u30a6\u30a4\u30eb\u30b9\u3000\u7814\u7a76\u53f2"],"language":"en","deposited":{"date-parts":[[2020,8,30]],"date-time":"2020-08-30T17:04:31Z","timestamp":1598807071000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsv\/64\/1\/64_67\/_article\/-char\/ja\/"}},"subtitle":["~ target cells of infection, and disease ~"],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2222\/jsv.64.67","relation":{},"ISSN":["0042-6857","1884-3433"],"issn-type":[{"value":"0042-6857","type":"print"},{"value":"1884-3433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}